@ Disclosed in a photosensitive material for the electrophotography, which comprises a dispersion of a charge-generating pigment in a charge-transporting medium composed mainly of a polyvinyl carbazole resin, wherein a perylene pigment represented by the following general formula:
wherein R, and R2 stand for a hydrogen atom or a substituted or unsubstituted alkyl or aryl group, is dispersed and incorporated as the charge-generating pigment in an amount of 1 to 40 parts by weight per 100 parts by weight of the polyvinyl carbazole resin and a halogeno-p-benzoquinone is further incorporated in an amount of 1 to 60 parts by weight per 100 parts by weight of the polyvinyl carbazole resin.
Matheus, Chemische Berichte, 1888, vol. 21, p. 1886
作者:Matheus
DOI:——
日期:——
JPH02304063A
申请人:——
公开号:JPH02304063A
公开(公告)日:1990-12-17
Heat Shock Protein 90 Inhibitors, Methods Of Preparing Same, And Methods For Their Use
申请人:Min Jaeki
公开号:US20120022070A1
公开(公告)日:2012-01-26
Novel classes of molecular chaperone Heat shock protein 90 (Hsp90) inhibitors are disclosed. These compounds are useful in treating and preventing cancer and other Hsp90-related diseases and conditions, such as inflammation and neurodegenerative disorders. Methods of treating and preventing cancer and other Hsp90 related diseases and conditions are disclosed that include administering to the subject a therapeutically effective amount of an Hsp90 inhibitor. Methods of preparing the novel Hsp90 inhibitors are also provided.
[EN] HEAT SHOCK PROTEIN 90 INHIBITORS, METHODS OF PREPARING SAME, AND METHODS FOR THEIR USE<br/>[FR] INHIBITEURS DE LA PROTÉINE DE CHOC THERMIQUE 90, LEURS PROCÉDÉS DE PRÉPARATION ET LEURS PROCÉDÉS D'UTILISATION
申请人:UNIV EMORY
公开号:WO2010042500A2
公开(公告)日:2010-04-15
Novel classes of molecular chaperone Heat shock protein 90 (Hsp90) inhibitors are disclosed. These compounds are useful in treating and preventing cancer and other Hsp90-related diseases and conditions, such as inflammation and neurodegenerative disorders. Methods of treating and preventing cancer and other Hsp90 related diseases and conditions are disclosed that include administering to the subject a therapeutically effective amount of an Hsp90 inhibitor. Methods of preparing the novel Hsp90 inhibitors are also provided.